Velodyne LiDAR and MADD (Mothers Against Drunk Driving) Launch Educational Campaign Addressing Autonomous Vehicles’ Potential to Reduce Roadway Fatalities
What if the designated driver of the future was a self-driving car? How would such technology solve the drunk driving epidemic? Velodyne LiDAR is proud to partner with Mothers Against Drunk Driving (MADD) to create an online educational destination with information on how autonomous vehicles can help prevent roadway collisions. The site explains the basics of autonomous driving in easy-to-understand language for all audiences. The September 30, 2018 site launch is the result of Velodyne LiDAR and MADD’s inaugural year of partnership.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181001005271/en/
Left to right: Wes Morgan, retired LPD officer, Carol Leister, MADD National Board Member, Dave Chesterman, father of 21 year old victim, Sally Frykman, Director of Education.
Coinciding with the Walk Like MADD event in San Francisco, Velodyne will publish a webpage spotlighting a series of informational videos. “Both Velodyne and MADD see this as a crucial move in their crusade against further casualties of impaired driving. Velodyne is eager to share its confidence that fully autonomous vehicles will spark global health benefits,” stated Sally Frykman, Velodyne LiDAR’s Director of Education and Business Development.
The webpage will feature content including the video “Jane: A Velodyne Story” - a narrative told through the animation of Demente Studio. The video depicts a near-future reality in which self-driving cars could make the difference between an ideal evening and catastrophe. In the story, Jane celebrates her 21st birthday by attending a concert with friends—only to fall asleep behind the wheel. Thankfully, LiDAR technology isn’t reliant on Jane to navigate safely, ensuring her safe return home to her parents.
Additional content modules include “LiDAR 101”, explaining how lidar sensor technology is an essential component of self-driving vehicles. Also included will be footage of the San Francisco Bay Area MADD Law Enforcement Recognition Event, a celebration of heroic first responders, as well as testimonials of first-hand experience of the benefits of autonomous vehicles.
“The promise of safe, self-driving cars is very exciting, particularly for those of us who have seen the devastation that impaired driving and human error can bring,” said MADD National President Colleen Sheehey-Church. Church’s 18-year-old son Dustin was killed in a car driven by a drunk and drugged driver. “MADD will continue to strongly support the safe development of this technology and will work with partners like Velodyne LiDAR to educate and build public acceptance of autonomous vehicle technology.”
“Velodyne LiDAR and MADD have joined forces because a drunk driving fatality every 49 minutes isn’t acceptable. It’s time fully autonomous vehicles became the answer to reducing, preventing, and potentially entirely eliminating human error on the roadway. And it’s essential that the public is aware and educated about technology as a solution to the problem,” stated Sally Frykman.
“MADD is highly respected in the country and in the world for the work that they do,” Velodyne President Marta Hall says. “The organization wants to save lives on the roadways. We share the same goal, which is better safety. We are proud to partner with MADD because our lidar technology provides real solutions to driving challenges. Together we are a wonderful team.”
Founded in 1983 and headquartered in Silicon Valley, Velodyne is a technology company known worldwide for its real-time 3D LiDAR computing and software platforms. The company evolved after founder/inventor David Hall developed the HDL-64 Solid-State Hybrid LiDAR sensor in 2005. Since then, Velodyne LiDAR Inc. has emerged as the unmatched market leader of real-time 3D vision systems used in a variety of commercial applications including autonomous vehicles, vehicle safety systems, mobile mapping, aerial mapping, and security. Its products range from the high-performance, surround view Ultra-Puck™ VLP-32, classic HDL-32/64 and cost-effective VLP-16 to the upcoming, hidden Velarray™ and now the 300-meter range VLS-128. Velodyne’s rich suite of perception software and algorithms are the key enablers of its perception systems. Velodyne supports customers from offices in San Jose, Detroit, Frankfurt, and Beijing. For more information, visit http://www.velodynelidar.com.
Founded in 1980 by a mother whose daughter was killed by a drunk driver, Mothers Against Drunk Driving® (MADD) is the nation’s largest nonprofit working to end drunk driving, help fight drugged driving, support the victims of these violent crimes and prevent underage drinking. MADD has helped to save more than 350,000 lives, reduce drunk driving deaths by more than 50 percent and promote designating a non-drinking driver. MADD’s Campaign to Eliminate Drunk Driving® calls for law enforcement support, ignition interlocks for all offenders and advanced vehicle technology. MADD has provided supportive services to nearly one million drunk and drugged driving victims and survivors at no charge through local victim advocates and the 24-Hour Victim Help Line 1-877-MADD-HELP. Visit www.madd.org or call 1-877-ASK-MADD.
Velodyne LiDAR, Inc.
Cesar A. Montero Orozco
Om Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
Telna Launches New eSIM Solution at MWC Barcelona 201924.2.2019 00:00:00 | Pressemelding
Telna, a vertically integrated Network-as-a-Service (NaaS) provider of global end-to-end connectivity solutions, today is adding eSIM technology to its platform. The new resilient and efficient eSIM architecture will be showcased at Mobile World Congress Barcelona 2019, from February 25th - February 28th at Telna’s booth in Hall 1, Stand 1B80. “eSIM technology is another example of a global trend in digital transformation set to disrupt cellular connectivity,” says Gregory Gundelfinger, CEO of Telna. “Our customers now have access to both Consumer and IoT/M2M eSIM that is bundled with the rest of our software-defined network services.” eSIM is an embedded SIM card, meaning there is no physical SIM card and no physical swapping of SIM cards. It's easy to add data plans and is endorsed by the GSMA. “The virtualization of the SIM card removes one of the largest barriers when switching between networks, the physical SIM card,” says Gundelfinger. The Telna eSIM allows users to access their
Hilton Launches New Brand, Signia Hilton, Delivering Sophisticated Travel While Reimagining Meetings and Events22.2.2019 17:00:00 | Pressemelding
Hilton (NYSE: HLT) today announced the launch of Signia Hilton, its dynamic, new meetings-and-events-focused brand. The portfolio of hotels is setting out to transform the industry for meeting professionals and sophisticated business travelers by infusing state-of-the-art technology and design into every aspect of the guest experience. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190222005071/en/ The brand further reinforces Hilton’s commitment to innovation that meets the evolving needs of today’s travelers and will bring premium experiences to top urban and resort destinations around the world. “In our 100th year of hospitality, we are more focused than ever on providing exceptional experiences to all of our guests – and that includes evolving those experiences to meet their changing needs,” said Christopher J. Nassetta, president and CEO, Hilton. “We are proud to launch Signia Hilton, which exemplifies our innovative sp
Axonics® Granted Expanded CE Mark Label; First and Only Sacral Neuromodulation System Approved for Use with Full-Body MRI Scans22.2.2019 16:30:00 | Pressemelding
Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company focused on the development and commercialization of novel implantable Sacral Neuromodulation (“SNM”) devices for the treatment of urinary and bowel dysfunction, announced today that it has received CE mark approval for 1.5T and 3T full-body magnetic resonance imaging (“MRI”) conditional labeling for the Axonics r-SNM® System. The Axonics r-SNM System is the only implantable SNM system that has received full-body MRI conditional labeling for sale in Europe1. Raymond W. Cohen, Chief Executive Officer of Axonics, said, “Without this labeling, any patient requiring an MRI scan on any body part below the head must have their neurostimulator surgically explanted prior to the MRI scan, resulting in an additional surgery for the patient and additional costs to patients and the healthcare system. This authorization of full-body MRI scans in Europe is another important milestone for Axonics, differentiating our te
Fantastec Joins Forces with Arsenal FC Launching Official Blockchain Collectibles App22.2.2019 14:30:00 | Pressemelding
Fantastec announced today its first football licensing agreement with Premier League club Arsenal FC for a new blockchain authenticated collectibles app called Fantastec SWAP. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190222005277/en/ Arsenal players appear on Fantastec SWAP in official licensing deal (Graphic: Business Wire) London-based Fantastec is a leading sports fan technology innovator, and its blockchain based ‘SWAP’ app will have broad appeal to global sports fans, gamers and sports card collectors alike. Fantastec SWAP unlocks unique and authentic club content through the app, like player autographs and exclusive footage. With its innovative blockchain technology, fans around the world can now discover, collect and swap officially licensed club collectibles with other fans with complete trust. “Fantastec SWAP is a game-changer for international football fans as well the sports collectibles industry,” commented
Volkswagen Protects Virtual Key Sharing App with Trustonic Application Protection22.2.2019 13:42:00 | Pressemelding
Volkswagen is working with mobile cyber security leader Trustonic to enable customers to use smartphones to access their vehicles, and to securely share their digital car keys to grant access to others via a smartphone app. Volkswagen is using the Trustonic Application Protection (TAP) platform to secure the mobile app and ensure that sensitive information and key transfer requests are securely displayed to, and approved by, a real authenticated user on a trusted device and not by hackers or malware simulating a user or device. “The smartphone is becoming the vehicle key of the future and our We Connect service is the interface for this today in the new Volkswagen Passat,” comments Alf Pollex, Head of Infotainment and Connected Car at Volkswagen AG. “The user installs the We Connect app on their smartphone which is then authorized via the infotainment system with a Transaction Number. The Mobile Key will be compatible with Android-based Samsung devices. No mobile network connection is
Mundipharma EDO GmbH: US FDA grants Orphan Drug Designation for etoposide toniribate in relapsed/refractory biliary tract cancer22.2.2019 13:30:00 | Pressemelding
Mundipharma EDO GmbH, part of the Mundipharma network of independent associated companies, and Imbrium Therapeutics L.P., an operating subsidiary of Purdue Pharma L.P., today announced that the US FDA has granted Orphan Drug Designation (ODD) to etoposide toniribate for the treatment of relapsed/refractory biliary tract cancer, also known as cholangiocarcinoma.3 This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190222005126/en/ Biliary tract cancer is a rare tumour with approximately 8,000 patients diagnosed in the US every year and 10,571 in Europe.4,5 The FDA grants ODD status to medicines intended for the treatment, diagnosis or prevention of rare diseases or disorders that affect fewer than 200,000 people in the US. Radical surgery is the only curative treatment for biliary tract cancer but, in most cases, the cancer is inoperable. Patients who fail first-line chemotherapy have limited treatment options and the standard of